Who Owns KMTS?

Kestra Medical Technologies, Ltd. — Institutional Ownership & 13F Holdings

$20.69

+1.18 (+6.05%)

Market Cap

$1.3B

Shares Outstanding

58,373,352

Institutional Holders

62

Total Inst. Value

$1.1B

% of Float Held

137.1%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BAIN CAPITAL INVESTORS LLC$673.3M27,019,225
2FMR LLC$79.7M3,199,044
3Yu Fan$56.9M2,282,519
4T. Rowe Price Investment Management, Inc.$56.6M2,271,755
5Omega Fund Management, LLC$44.8M1,795,893
6ALLIANCEBERNSTEIN L.P.$29.5M1,183,773
7Holocene Advisors, LP$24.9M999,459
8PRICE T ROWE ASSOCIATES INC /MD/$21.2M849,418
9BROWN ADVISORY INC$13.7M550,418
10FEDERATED HERMES, INC.$10.0M400,000

Related Stocks

Frequently Asked Questions

How many institutional investors hold KMTS?

As of Q1 2025, 62 institutional investors report holding KMTS (Kestra Medical Technologies, Ltd.) in their 13F filings.

What percentage of Kestra Medical Technologies, Ltd. is owned by institutions?

Institutional investors hold approximately 137.1% of Kestra Medical Technologies, Ltd.'s float as reported in SEC 13F filings.

Which hedge fund owns the most KMTS?

The largest institutional holder of KMTS is BAIN CAPITAL INVESTORS LLC with $673.3M in shares.

Are institutions buying or selling KMTS?

This quarter, 62 institutions opened new positions in KMTS and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.